[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100419506":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":10,"locations":30,"responsibleParty":50,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Jonsson Comprehensive Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ancillary-correlative (biospecimen collection)",null,"Patients undergo collection of blood samples on the day of surgery following anesthesia but prior to incision and at the first routine blood test following surgery. Patients who undergo remnant ablation after total thyroidectomy with radioactive iodine have an additional blood sample collected. Patients also undergo collection of tissue samples following surgical resection of thyroid nodule or thyroid cancer. Patients' medical records are also reviewed.",[13,14],"Procedure: Biospecimen Collection","Other: Electronic Health Record Review",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"PROCEDURE","Biospecimen Collection","Undergo collection of blood and tissue samples",[9],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Electronic Health Record Review","Medical charts are reviewed",[9],[26],{"name":27,"affiliation":28,"role":29},"James Wu","UCLA \u002F Jonsson Comprehensive Cancer Center","PRINCIPAL_INVESTIGATOR",[31],{"facility":28,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Los Angeles","California","90095","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-118.24368,34.05223,{"lat":42,"lon":41},[45,49],{"name":27,"role":46,"phone":47,"phoneExt":10,"email":48},"CONTACT","303-518-3186","jameswu@mednet.ucla.edu",{"name":27,"role":29,"phone":10,"phoneExt":10,"email":10},{"type":51,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100419506","development-of-liquid-biopsy-technologies-for-noninvasive-cancer-diagnostics-in-patients-with-suspicious-thyroid-nodules-or-thyroid-cancer-100419506",false,"NCT04742608","Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer","Isolation and Characterization of Extracellular Vesicles in Patients With Thyroid Nodules and Thyroid Cancer","Inclusion Criteria:\n\n* Aged 18 and older\n* Consented for thyroid surgery for thyroid cancer or indeterminate thyroid nodule\n\nExclusion Criteria:\n\n* Patients with concurrent malignancy","ALL","18 Years",{"count":62,"type":63},250,"ESTIMATED","OBSERVATIONAL","This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.",[67,68],"Thyroid Gland Carcinoma","Thyroid Gland Nodule","2026-03-06",{"date":71,"type":72},"2026-03-10","ACTUAL",{"date":74,"type":72},"2020-02-21",{"date":76,"type":63},"2027-02-01",{"name":5,"class":6},1]